Airdrie, United Kingdom

George McGarry


Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1981-1994

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by George McGarry

Introduction

George McGarry is a notable inventor based in Airdrie, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on developing compounds that address critical health issues, particularly in the treatment of heart failure and bronchoconstriction.

Latest Patents

One of McGarry's latest patents involves the use of a benzo[b]thiopene-2-carboximidamide derivative. This invention relates to a medicament suitable for treating heart failure, characterized by high bioavailability without inducing nausea, vomiting, or restlessness. Another significant patent addresses compounds with bronchodilator activity. This method is designed for treating patients suffering from bronchoconstriction, especially during asthmatic attacks, utilizing various derivatives represented by specific chemical formulas.

Career Highlights

George McGarry has built a reputable career in the pharmaceutical industry. He is currently associated with Akzo N.V., where he continues to innovate and develop new therapeutic solutions. His work has been instrumental in advancing treatments that improve patient outcomes.

Collaborations

Throughout his career, McGarry has collaborated with notable colleagues, including Robert T. Logan and Robert G. Roy. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

George McGarry's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective treatments. His patents reflect a deep understanding of medicinal chemistry and a dedication to addressing significant health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…